Acceptability and Preferences of Long-Acting Injectable Pre-Exposure Prophylaxis and Antiretroviral Therapy Among Men Who Have Sex With Men and People Who Inject Drugs in India: Insights for Future Implementation. [PDF]
McFall AM +8 more
europepmc +1 more source
Interest in HIV pre-exposure prophylaxis use and associated factors among people who inject drugs in Iran: a nationwide survey in 2023. [PDF]
Moameri H +13 more
europepmc +1 more source
Housing and displacement as risk factors for negative health outcomes among people who inject drugs in Los Angeles, CA, and Denver, CO, USA. [PDF]
Goldshear JL +6 more
europepmc +1 more source
Barriers and facilitators to initiating and adhering to harm reduction services among people who inject drugs in the United States: a systematic review. [PDF]
Nacht CL +7 more
europepmc +1 more source
Related searches:
Global epidemiology of injecting drug use and HIV among people who inject drugs: a systematic review
Lancet, The, 2008BACKGROUND Injecting drug use is an increasingly important cause of HIV transmission in most countries worldwide. Our aim was to determine the prevalence of injecting drug use among individuals aged 15-64 years, and of HIV among people who inject drugs.
Bradley Mathers +2 more
exaly +2 more sources
Understanding healthcare engagement for people who inject drugs
Research in Nursing & Health, 2023AbstractPeople who inject drugs (PWID) are at an increased risk of multimorbid mental health and chronic diseases, which are frequently underdiagnosed and under‐treated due to systemic barriers and ongoing substance use. Healthcare engagement is essential to address these conditions and prevent excess morbidity and mortality. The goal of this study was
Omeid Heidari +6 more
openaire +3 more sources
BACKGROUND Opioid overdoses are a leading cause of injury death in the United States. Providing people who inject drugs (PWID) with naloxone is essential to preventing deaths. However, research regarding gaps in naloxone delivery is limited. METHODS We
Elizabeth N Kinnard +2 more
exaly +2 more sources

